StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.29−0.01 (-0.23%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Precigen total assets

Total assets on the balance sheet at the end of each period.

Precigen's total assets was $170.30M at Jun 30, 2026. For fiscal 2025 it was $155.51M, up 7.0% from the year before. Over ten years it grew -16.8% a year on average. The highest annual figure on record is $982.05M in fiscal 2015.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$155.51M+7.0%
FY2024Dec 31, 2024$145.27M-3.8%
FY2023Dec 31, 2023$151.04M-30.1%
FY2022Dec 31, 2022$215.98M-40.0%
FY2021Dec 31, 2021$359.86M+14.4%
FY2020Dec 31, 2020$314.59M-31.0%
FY2019Dec 31, 2019$455.76M-36.4%
FY2018Dec 31, 2018$716.18M-15.4%
FY2017Dec 31, 2017$846.85M-10.8%
FY2016Dec 31, 2016$949.07M-3.4%
FY2015Dec 31, 2015$982.05M+70.4%
FY2014Dec 31, 2014$576.27M+22.7%
FY2013Dec 31, 2013$469.47M+209.6%
FY2012Dec 31, 2012$151.65M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$170.30M+67.1%
Q1 FY2026Mar 31, 2026$138.63M+7.6%
Q4 FY2025Dec 31, 2025$155.51M+7.0%
Q3 FY2025Sep 30, 2025$171.26M+105.2%
Q2 FY2025Jun 30, 2025$101.90M+39.3%
Q1 FY2025Mar 31, 2025$128.79M-4.5%
Q4 FY2024Dec 31, 2024$145.27M-3.8%
Q3 FY2024Sep 30, 2024$83.47M-56.2%
Q2 FY2024Jun 30, 2024$73.16M-64.7%
Q1 FY2024Mar 31, 2024$134.85M-44.2%
Q4 FY2023Dec 31, 2023$151.04M-30.1%
Q3 FY2023Sep 30, 2023$190.69M-26.4%
Q2 FY2023Jun 30, 2023$207.53M-35.4%
Q1 FY2023Mar 31, 2023$241.55M-28.0%
Q4 FY2022Dec 31, 2022$215.98M-40.0%
Q3 FY2022Sep 30, 2022$259.25M-31.2%
Q2 FY2022Jun 30, 2022$321.22M-20.2%
Q1 FY2022Mar 31, 2022$335.57M-17.5%
Q4 FY2021Dec 31, 2021$359.86M+14.4%
Q3 FY2021Sep 30, 2021$376.90M+12.1%
Q2 FY2021Jun 30, 2021$402.57M+11.3%
Q1 FY2021Mar 31, 2021$406.98M+0.6%
Q4 FY2020Dec 31, 2020$314.59M-31.0%
Q3 FY2020Sep 30, 2020$336.19M-44.4%
Q2 FY2020Jun 30, 2020$361.72M-44.8%
Q1 FY2020Mar 31, 2020$404.67M-43.0%
Q4 FY2019Dec 31, 2019$455.76M-36.4%
Q3 FY2019Sep 30, 2019$604.91M-38.3%
Q2 FY2019Jun 30, 2019$655.19M-20.6%
Q1 FY2019Mar 31, 2019$709.86M-20.7%
Q4 FY2018Dec 31, 2018$716.18M-15.4%
Q3 FY2018Sep 30, 2018$980.42M+9.1%
Q2 FY2018Jun 30, 2018$825.15M-11.7%
Q1 FY2018Mar 31, 2018$895.67M-2.2%
Q4 FY2017Dec 31, 2017$846.85M-10.8%
Q3 FY2017Sep 30, 2017$898.26M-10.7%
Q2 FY2017Jun 30, 2017$933.99M–
Q1 FY2017Mar 31, 2017$915.93M–
Q4 FY2016Dec 31, 2016$949.07M–
Q3 FY2016Sep 30, 2016$1.01B–

More Precigen figures

See a number that looks wrong?